PRODUCTS
SERVICES
The primary investment objective of the Scheme is to generate consistent returns by investing in equity / equity related or fixed income securities of Pharma and other associated companies
1.82
20 yrs 10 m
1%
8,080.97 Crs
1% on or before 1M, Nil after 1M
Large Growth
8.65
SIP 100 & Lumpsum 5000
NA
Sailesh Raj Bhan
Investors understand that their principal will be at very high risk